Trending Articles

Merck stops coronavirus vaccine development in surprise setback

Bio Pharma Dive

The drugmaker, one of the largest vaccine developers globally, won't move forward with either of two candidates it's been testing after disappointing data in early trials

Is pharma digital ready?

World of DTC Marketing

SUMMARY: Digital is a way of thinking; it’s not a tactic. To many going digital can mean a ton of opportunities but if you move too quickly you can lose sight of the end goal. Is your organization digital ready?


Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

In ED patients with chest and abdominal pain, care delivered by physicians and APPs is similar



How Food Delivery is Exacerbating Climate Change


It’s no secret that food delivery usage has skyrocketed over the course of the pandemic. With stay-at-home orders and strict guidelines for restaurants, many have turned to food delivery to fulfill cravings, and restaurants that have managed to survive so far have used it as a lifeline.

Pfizer Will Ship Fewer Covid-19 Vaccine Vials to Account for ‘Extra’ Doses

NY Times

After the surprise discovery of an extra dose in every vial, Pfizer executives successfully lobbied the F.D.A. to change the vaccine’s formal authorization language. The company charges by the dose.

How 2 scientific pioneers teamed up to run AskBio, Bayer's new gene therapy division

Bio Pharma Dive

Katherine High and Jude Samulski, two well-known gene therapy researchers, were longtime collaborators and competitors. Now they're colleagues at one of the world's largest drugmakers

The complicated ROI measurement for pharma

World of DTC Marketing

SUMMARY: The LinkedIn team had a unique take on measuring ROI. “77% of marketers measure ROI within the first month of their campaign, knowingly trying to “prove ROI in a shorter amount of time than their typical sales cycle.,

More Trending

How To Minimize the Complexities of Social Distancing in the Laboratory


The COVID-19 pandemic has changed working life around the world, with lockdowns forcing millions to work remotely while balancing their home and child-care responsibilities. However, many types of work cannot be completed remotely, including medical care, food service and transportation.

Thrombocytopenia Drugs Market: What Newer Agents Are Expected To Enter The Market?


The launch of a novel drug in the market is not less than a celebration in the pharmaceutical and healthcare market; however, it also brings the real challenge of sustenance in the market. Similar is the picture of the Thrombocytopenia Drugs Market.

FDA approves first-of-its-kind lupus drug

Bio Pharma Dive

Lupkynis, the first oral drug approved for lupus nephritis, comes with a high list price. Its developer, Aurinia Pharmaceuticals, expects average net revenue of roughly $65,000 per patient per year

The importance of your product website

World of DTC Marketing

SUMMARY: Among US adults who looked for health information and used the internet for their most recent search, the percentage who reported accessing health information without frustration was stable during the study period (from 37.2% in 2008 to 38.5% in 2017).

Spotlight on EU executive’s handling of vaccine supply contracts

BioPharma Reporter

The European Ombudsman is investigating the secrecy with which the EU executive is handling COVID-19 vaccine supply contracts. Markets & Regulations

New Year, Same Pandemic. Progress Made, But the Fight Goes On

Imperical Blog

It’s 2021 – Happy New Year to you and yours. The change of the calendar from December 31 to January 1 is a symbolic milestone for a new start, a clean slate, to turn over a new leaf, (insert your saying here). This year is no different.

How Startup SAVRPak is Preventing Soggy Food Delivery, One Fry at a Time


Thanks to food delivery apps, ordering food is just a few taps or a phone call away. But when it arrives, the quality of the food doesn’t always match up to that of dining in — perhaps that salad is slightly soggy or those fries have lost some of their crunch.

Pfizer, BioNTech say vaccine effective against fast-spreading UK coronavirus variant

Bio Pharma Dive

BioNTech's CEO has also promised data will soon be available on the shot's protection against a South African variant that's worried public health experts

Roche’s Macular Degeneration Drug Hits Mark in Two Phase III Trials


Roche announced topline data from two identical Phase III trials, TENAYA and LUCERNE, of faricimab in neovascular or “wet” age-related macular degeneration (nAMD

AstraZeneca and University of Oxford dismiss German media claims about vaccine efficacy in elderly

BioPharma Reporter

AstraZeneca along with its scientific partners at the University of Oxford have rejected German media reports that their vaccine against COVID-19 had low efficacy in people aged over 65. Markets & Regulations

Gilead says Veklury should work against COVID-19 variants

Pharma Phorum

Gilead Sciences says its antiviral Veklury should be effective against the new, more contagious COVID-19 variants discovered in the UK and South Africa.

Antibiotic resistance may spread even more easily than expected


Credit: Jan Zrimec/Chalmers University of Technology Pathogenic bacteria in humans are developing resistance to antibiotics much faster than expected.

Moderna to study vaccine booster aimed at coronavirus variant

Bio Pharma Dive

Laboratory tests indicated the biotech's shot would still protect against virus variants detected in the U.K. and South Africa, although the latter appeared to result in a weaker immune response

Seasonal Flu Nearly Eradicated During Pandemic, Despite Rising COVID-19 Cases


Despite the rising number of COVID-19 cases reported across the globe, rates of influenza have virtually flatlined across the Northern Hemisphere, leading many doctors and researchers to wonder how this could be replicated in non-pandemic times

Pfizer/BioNTech COVID-19 vaccine is safe for elderly people, says WHO

BioPharma Reporter

The World Health Organizationâs Global Advisory Committee on Vaccine Safety says it has not seen any unexpected or untoward increase in fatalities in frail and elderly individuals who have received the Pfizer/BioNTech vaccine. Markets & Regulations

IconOVir raises $77M to Fight Cancer with Viruses


San Diego’s IconOVir Bio has raised $77 million in Series A financing to develop differentiated oncolytic virus candidates which the company believes could be tumor-selective to infect and destroy tumor cells. The financing was co-led by Nextech and Vida Ventures.

Deep sleep takes out the trash


Waste clearance is crucial for brain health, preventing neurodegenerative disease Credit: Ravi Allada/Northwestern University A new Northwestern University study reaffirms the importance of getting a good night’s sleep.

Lilly's antibody drug prevents COVID-19 in study, but hurdles to use remain

Bio Pharma Dive

Results from a clinical trial in nursing home residents and staff offered the first evidence Lilly's bamlanivimab could protect against, as well as treat, COVID-19

Nurses 199

Aurinia Makes History as FDA Approves First Oral Drug for Lupus Nephritis


The U.S. Food and Drug Administration gave the green light to Aurinia’s Lupkynis (voclosporin) in combination with a background immunosuppressive therapy regimen for LN

Merck exits COVID-19 vaccine development, cites disappointing data

BioPharma Reporter

Merck is shutting down the programs linked to its two COVID-19 vaccine candidates following early trial data indicating that they failed to generate immune responses comparable to a natural infection or existing vaccines. Bio Developments

GSK suffers another R&D setback, axing ulcerative colitis drug trial

Pharma Phorum

GlaxoSmithKline has suffered another research setback after it axed a phase 2 trial of an anti-LAG3 drug in patients with ulcerative colitis, following a major disappointment with a key lung cancer drug last week.

How did Florida fail to respond to a coral disease epizootic and what’s to follow?


Credit: William Precht By 2020, massive losses of large populations of corals have been observed throughout Florida and into the greater Caribbean basin.


Can new Regeneron, Lilly data move the needle for COVID-19 antibody drugs?

Bio Pharma Dive

The results show that drugs from both companies can help prevent or treat COVID-19 when given at the right time. But that won't mean much if barriers to use remain high

Over-the-Counter Nasal Spray Could Be Effective Against COVID-19


An in vitro study conducted by scientists from Northwestern University and Utah State University concluded that components found within the Xlear nasal spray, particularly grapefruit seed extract and xylitol, were successful in statistically reducing the amount of SARS-CoV-2 in a patient

Moderna developing COVID-19 vaccine booster shot against South Africa variant

BioPharma Reporter

An in vitro study shows Moderna's existing mRNA COVID-19 vaccine provides protection against strains that have emerged from South Africa and the UK.

Eli Lilly Claims Drug Prevents Coronavirus Infection in Nursing Homes

NY Times

A monoclonal antibody protected residents and staff members in facilities where the virus had appeared. Antibodies Drugs (Pharmaceuticals) Nursing Homes Disease Rates Elderly Coronavirus (2019-nCoV) Vaccination and Immunization Elder Care Deaths (Fatalities) Eli Lilly and Company United States

Breakthrough design at UBCO vastly improves mechanical heart valve


A twist on the decade’s-old design improves blood flow, prevents clots Credit: UBCO New research coming out of UBC’s Okanagan campus may take the current ‘gold standard’ for heart valves to a new level of reliability.

Long-acting HIV drug secures FDA approval, giving GSK a competitive boost

Bio Pharma Dive

Rather than a once-a-day pill, Cabenuva comes as a once-a-month injection. That convenience could become a valuable tool for GSK as it tries to broaden adoption of two-drug treatments

Study: Eli Lilly’s COVID-19 Antibody Protects the Most Vulnerable from Infection


Protecting the most vulnerable, Eli Lilly’s bamlanivimab significantly reduced COVID-19 risk for nursing home residents in a Phase III trial

Thousand Oaks Biopharmaceuticals Inked a Joint Venture Agreement with Korea’s WSG Group

BioTech 365

Thousand Oaks Biopharmaceuticals Inked a Joint Venture Agreement with Korea’s WSG Group Thousand Oaks Biopharmaceuticals Inked a Joint Venture Agreement with Korea’s WSG Group THOUSAND OAKS, Calif. &